Bio-Rad Laboratories, Inc.
BIO
$251.15
$0.140.06%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.73% | 1.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.73% | 1.76% | |||
| Cost of Revenue | 10.80% | 3.91% | |||
| Gross Profit | -3.93% | 0.05% | |||
| SG&A Expenses | 2.01% | 2.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.17% | 8.77% | |||
| Operating Income | -10.28% | -35.75% | |||
| Income Before Tax | -205.49% | 130.92% | |||
| Income Tax Expenses | -192.64% | 133.58% | |||
| Earnings from Continuing Operations | -209.59% | 130.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -209.59% | 130.16% | |||
| EBIT | -10.28% | -35.75% | |||
| EBITDA | -6.12% | -24.42% | |||
| EPS Basic | -209.40% | 130.64% | |||
| Normalized Basic EPS | -6.37% | -37.09% | |||
| EPS Diluted | -209.54% | 130.60% | |||
| Normalized Diluted EPS | -6.25% | -37.17% | |||
| Average Basic Shares Outstanding | 0.17% | -1.57% | |||
| Average Diluted Shares Outstanding | 0.04% | -1.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
